Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
Conditions
- Brain and Central Nervous System Tumors
- Childhood Germ Cell Tumor
- Kidney Cancer
- Liver Cancer
- Neuroblastoma
- Ovarian Cancer
- Sarcoma
- Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
- DRUG: carboplatin
- DRUG: talabostat mesylate
- DRUG: temozolomide
- OTHER: pharmacological study
Sponsor
National Institutes of Health Clinical Center (CC)
Collaborators